The implants are mainly used to treat pelvic fractures as well as fractures in the long bones of the arms and legs, according to a July 20 news release from the university.
With the approval, the system can be marketed and sold in the U.S.
This is the first FDA clearance the university has received for a novel medical device, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
